Advanced search
Publication Cover
mAbs Volume 16, 2024 - Issue 1
Submit an article Journal homepage
1,553
Views
0
CrossRef citations to date
0
Altmetric
Meeting Report

Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals

Sophie Tourdota Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Andover, MA, USACorrespondence[email protected]
View further author information
,
Daniel Baltrunkonisb Research and Development, Clinical Pharmacology and Bioanalytics, Clinical Bioanalytics, Groton, CT, USAView further author information
,
Sofie Deniesc SD Analytics, Bellem, BelgiumView further author information
,
Viswanath Devanarayand Eisai Inc, Nutley, NJ, USAView further author information
,
Joanna Grudzinska-Goebele DMPK Project Management, Pharmaceuticals R&D, Bayer AG, Berlin, GermanyView further author information
,
Arno Krommingaf BioNTech SE, Mainz, GermanyView further author information
,
Gregor P. Lotzg Roche Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Hoffmann-La Roche Ltd, Penzberg, GermanyView further author information
,
Laurent Malherbeh Lilly Research Laboratories, a Division of Eli Lilly and Company, Indianapolis, IN, USAView further author information
,
Lydia Michauti Novartis Biomedical research, PK Sciences, Basel, SwitzerlandView further author information
,
Karin N. Weldinghj Department of Clinical Immunogenicity Analysis, Novo Nordisk A/S, Maaloev, DenmarkView further author information
,
Joao A. Pedras-Vasconcelosk Division of Biotech Review and Research III, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USAView further author information
,
Laura. I. Salazar-Fontanal LAIZ Regulatory Science, Lausanne, SwitzerlandView further author information
,
Sebastian Spindeldreherm Integrated Biologix GmbH, Basel, SwitzerlandView further author information
,
Zuben Saunan Division of hemostasis, Office of Plasma Protein Therapeutics; Office of Therapeutic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USAView further author information
,
Veerle Snoecko Translational Biomarkers and Bioanalysis, UCB Biopharma SRL, Braine-l’Alleud, BelgiumView further author information
,
Daniela Verthelyip Division of Biologics Research and Review III; Ofrfice of Biotechnology Products; Center for Drug Evaluation and Research; Office of Pharmaceutical Quality, US Food and Drug Administration, Silver Spring, MD, USAView further author information
&
Daniel Kramerq Global Scientific Advisor Immunogenicity, Translational Medicine & Early Development, Sanofi Aventis Deutschland GmbH, Frankfurt am Main, GermanyView further author information
 show all
Article: 2324801 | Received 30 Jan 2024, Accepted 13 Feb 2024, Published online: 05 Mar 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.